ArticleEndocrine oncology (Bristol, England)2024

Peptide receptor radionuclide therapy for ectopic Cushing's syndrome caused by metastatic neuroendocrine neoplasms.

Emma Boehm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.